Skip to main content

AMGEN INC

For the period ended Jun 30, 2025. Filed Aug 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 6, 2025

AMGN$465.230.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

Three months endedJune 30,Six months endedJune 30,
2025202420252024
Revenues:
Product sales$8,771$8,041$16,644$15,159
Other revenues408347684676
Total revenues9,1798,38817,32815,835
Operating expenses:
Cost of sales3,0113,2365,9796,436
Research and development1,7441,4473,2302,790
Selling, general and administrative1,6911,7853,3783,593
Other7711907116
Total operating expenses6,5236,47913,49412,935
Operating income2,6561,9093,8342,900
Other income (expense):
Interest expense, net(694)(808)(1,417)(1,632)
Other (expense) income, net(394)(307)1,124(542)
Income before income taxes1,5687943,541726
Provision for income taxes1364837993
Net income$1,432$746$3,162$633
Earnings per share:
Basic$2.66$1.39$5.88$1.18
Diluted$2.65$1.38$5.84$1.17
Weighted-average shares used in calculation of earnings per share:
Basic538537538537
Diluted541541541541
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.